PIM1 and neoplasm: SEL24/MEN1703 demonstrated on-target activity as a pan-PIM inhibitor, inhibiting the cell proliferation of various diffuse large B-cell lymphoma (DLBCL) cell lines and DLBCL tumour growth in murine xenograft models.